WallStSmart

American International Group Inc (AIG)vsDrugs Made In America Acquisition Corp. Ordinary Shares (DMAA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

AIG leads profitability with a 11.8% profit margin vs 0.0%. AIG trades at a lower P/E of 13.5x. AIG earns a higher WallStSmart Score of 69/100 (B-).

AIG

Strong Buy

69

out of 100

Grade: B-

Growth: 4.7Profit: 5.5Value: 7.0Quality: 5.0
Piotroski: 4/9Altman Z: 0.67

DMAA

Avoid

34

out of 100

Grade: F

Growth: 5.7Profit: 3.5Value: 4.0Quality: 5.3
Piotroski: 2/9

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AIG5 strengths · Avg: 8.6/10
Price/BookValuation
1.1x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.239/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.638/10

Growing faster than its price suggests

P/E RatioValuation
13.5x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
21.6%8/10

Earnings expanding 21.6% YoY

DMAA1 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Areas to Watch

AIG3 concerns · Avg: 3.0/10
Revenue GrowthGrowth
1.4%4/10

1.4% revenue growth

Return on EquityProfitability
7.8%3/10

ROE of 7.8% — below average capital efficiency

Altman Z-ScoreHealth
0.672/10

Distress zone — elevated risk

DMAA4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

Market CapQuality
$258.06M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
2.8%3/10

ROE of 2.8% — below average capital efficiency

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : AIG

The strongest argument for AIG centers on Price/Book, Debt/Equity, PEG Ratio. PEG of 0.63 suggests the stock is reasonably priced for its growth.

Bull Case : DMAA

The strongest argument for DMAA centers on Debt/Equity.

Bear Case : AIG

The primary concerns for AIG are Revenue Growth, Return on Equity, Altman Z-Score.

Bear Case : DMAA

The primary concerns for DMAA are Revenue Growth, Market Cap, Return on Equity. A P/E of 53.1x leaves little room for execution misses.

Key Dynamics to Monitor

AIG is growing revenue faster at 1.4% — sustainability is the question.

AIG generates stronger free cash flow (155M), providing more financial flexibility.

Monitor INSURANCE - DIVERSIFIED industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AIG scores higher overall (69/100 vs 34/100). Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

American International Group Inc

FINANCIAL SERVICES · INSURANCE - DIVERSIFIED · USA

American International Group, Inc., also known as AIG, is an American multinational finance and insurance corporation with operations in more than 80 countries and jurisdictions. The company operates through three core businesses: General Insurance, Life & Retirement, and a standalone technology-enabled subsidiary.

Drugs Made In America Acquisition Corp. Ordinary Shares

FINANCIAL SERVICES · SHELL COMPANIES · USA

Drugs Made In America Acquisition Corp. (DMAA) is a special purpose acquisition company aimed at transforming the U.S. pharmaceutical industry by fostering strategic partnerships with innovative healthcare enterprises. With a commitment to enhancing domestic drug production and addressing critical supply chain vulnerabilities, DMAA seeks to ensure the availability of affordable medications for consumers. By leveraging cutting-edge technologies and promoting local manufacturing initiatives, DMAA is well-positioned to play a pivotal role in reshaping the landscape of pharmaceutical access in the United States.

Want to dig deeper into these stocks?